Results 171 to 180 of about 40,959 (251)

Comparative effectiveness of alternative times to opioid agonist treatment taper initiation on taper completion and all‐cause mortality among people with opioid use disorder: A retrospective population‐based target trial emulation study in British Columbia, Canada, 2010–2020

open access: yesAddiction, Volume 121, Issue 10, Page 2794-2806, October 2026.
Abstract Background and aims Opioid use disorder (OUD) treatment guidelines worldwide recommend opioid agonist treatment (OAT) as a long‐term, potentially indefinite treatment for managing OUD. However, many individuals express a strong interest in eventually tapering fully off treatment.
Ruyu Yan   +13 more
wiley   +1 more source

Disciplining the “Queen of the World”? Responsible Innovation as a Way of Life

open access: yesBusiness Ethics, the Environment &Responsibility, Volume 35, Issue 4, Page 3713-3724, October 2026.
ABSTRACT This paper offers a critical reflection on the concept of responsible innovation as defined during the last decades. We argue that the emphasis on innovation as a process risks neglecting the very goals of innovation, namely societal desirability and acceptability. Thus, we suggest reconsidering the role of imagination, the “Queen of the world”
Xavier Pavie   +2 more
wiley   +1 more source

Fixed-duration cytarabine consolidation improves relapse-free survival over indefinite AZA-VEN in younger AML. [PDF]

open access: yesBlood Cancer J
Swain RN   +9 more
europepmc   +1 more source

On the Destruction and Humanitarianisation of the Health System in Gaza and the Need for a Biopolitical Bioethics

open access: yesBioethics, Volume 40, Issue 8, Page 793-807, October 2026.
ABSTRACT This paper examines Israel's destruction and ‘humanitarianisation’ of Palestinian health systems, arguing that this should be understood as an instance of ‘necropolitics,’ as conceived by Achille Mbembe. We review the extensive, long‐term destruction of health systems in Palestine before 7 October 2023 and the catastrophic acceleration of that
Mohammad Salaymeh   +2 more
wiley   +1 more source

Early Weight Regain After GLP‐1 Receptor Agonist Discontinuation: Mechanisms and Implications for Treatment De‐Escalation Strategies

open access: yesDiabetes, Obesity and Metabolism, Volume 28, Issue 10, Page 8769-8776, October 2026.
ABSTRACT Glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs) have transformed the pharmacological management of obesity, producing substantial and sustained weight loss during active treatment. However, discontinuation of therapy is frequently followed by significant weight regain, raising important questions regarding the durability of treatment ...
M. A. Damhof   +2 more
wiley   +1 more source

Coccidioidal Peritonitis: Clinical Characteristics, Treatment and Outcomes. [PDF]

open access: yesJ Fungi (Basel)
Shubeilat JL   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy